AN2 Therapeutics

Public

Menlo Park, CaliforniaHealthcarehttps://www.an2therapeutics.com

Last Round

Follow-on Offering

Mar 25, 2026

Total Funding Raised

$40M

Company Overview

AN2 Therapeutics (NAS: ANTX) is a biopharmaceutical company focused on developing innovative treatments for rare and serious infectious diseases with significant unmet medical needs.

Sector

Healthcare

AI Layer

Non-AI

Keywords

boron chemistry drug discovery platformsmall molecule therapeutics for infectious diseasesoral therapeutic for non-tuberculous mycobacterial (NTM) lung diseaseleucyl-tRNA synthetase inhibitortherapeutics for rare infectious diseasestherapeutics for M. abscessus lung diseaseChagas disease therapeutic developmentmelioidosis treatment developmentdrug development for difficult-to-treat infectionsdrug commercialization licensing modelglobal health infectious disease researchpreclinical oncology program

AN2 Therapeutics Comps

Public and private peers based on sector, stage, and business model.

AN2 Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AN2 Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Follow-on Offering	Mar 25, 2026

View all Funding Rounds

AN2 Therapeutics Investors

Notable investors and investment history

AN2 Therapeutics investors
Investor	Rounds
Coastlands Capital LP	Follow-on Offering
Commodore Capital	Follow-on Offering
Vivo Capital	Follow-on Offering

View all Investors

AN2 Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AN2 Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersMenlo Park, California

Employee Range35

Year Founded2019

Last FundingMar 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.